Historeceptomics Profiling of Ketamine
Ketamine elicits distinctive neuropsychiatric phenotypes from a complex and as yet elusive mechanism of action. Here, we applied an updated Historeceptomics approach to identify molecular targets and brain tissues that may contribute to its antidepressant, analgesic, and dissociative effects. Historeceptomics generates multidimensional target-tissue fingerprints by integrating drug-target activity with tissue-specific target expression, providing an anatomic profile of drug action. The results suggest that ketamine activity on NMDA receptors in the prefrontal and cingulate cortices and the amygdala may contribute to ketamine improvements in social functioning for MDD. However, this same receptor-tissue activity may invoke hallucinatory effects at higher intensity or with engagement of additional brain regions. The central nervous system (CNS) fingerprint for ketamine was compared with those of other psychoactive drugs, showing overlap with fingerprints from other antidepressant, hallucinogenic, and analgesic drugs. Some ketamine effects may be traced to specific enantiomers or metabolites of ketamine. These findings provide new insights into the mechanisms by which ketamine elicits its unique phenotype and demonstrate the utility of using Historeceptomics to understand complex drug action.
Authors
- Eric H. Rosenn (ORCID: https://orcid.org/0009-0000-6084-8933)
- Timothy J. Cardozo (ORCID: https://orcid.org/0000-0002-0643-4497)
- Jennifer A. Fuller (ORCID: https://orcid.org/0000-0001-6609-8715)
- Harrison Agnor
Institutions
- NYU Langone Health (US)
- New York University (US)
Publication Details
- Journal
- bioRxiv (Cold Spring Harbor Laboratory)
- Published
- 2026-11-19
- DOI
- https://doi.org/10.64898/2026.11.18.767642
- Primary Topic
- Treatment of Major Depression
- Type
- preprint